CapsoVision, Inc (CV)
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
CapsoVision, Inc.
Recent SEC filings with analysis
- 8-KCapsoVision entered into a securities purchase agreement on September 17, 2026 for a registered direct offering of 3,163,444 common shares at $5.69 per share,…
- 424B5CapsoVision priced a registered direct offering of 3,163,444 common shares at $5.69 per share, roughly a 5% discount to the $5.99 last reported sale price, for…